Search clinical trials for: Herceptin EU

Total 776 results

Prestige Biopharma Limited

Completed

A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects (TROIKA-1)

Healthy Volunteers

Australia
EirGenix, Inc.

Completed

A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers

Healthy
Alteogen, Inc.
Cristália Produtos Químicos Farmacêuticos Ltda.

Completed

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects

Healthy
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects

Healthy

Germany
Mylan Pharmaceuticals Inc
Mylan GmbH

Completed

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

Healthy
Shanghai Henlius Biotech

Completed

A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects

Healthy

China
Vrije Universiteit Brussel
University of British Columbia; University of Coimbra; Amsterdam UMC, location... and other collaborators

Not yet recruiting

International Study to Evaluate a Navigation Program for Older People With Cancer and Their Family Caregivers (EU NAVIGATE Study) (EU NAVIGATE)

Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative
University of North Carolina, Chapel Hill

Completed

A Study of Inhalation of 20,000 EU CCRE and Mucociliary Clearance (MCC) in Otherwise Healthy Individuals Who Are Current Cigarette Smokers (IRB 09-0259)

Healthy | Cigarette Smoking

United States
Ruhr University of Bochum

Completed

Tachosil for the Prevention of Symptomatic Lymph Cysts

Cervical Cancer | Endometrial Cancer

Austria, Germany
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Rheumatoid Arthritis

Hungary, Serbia, Georgia, Russian Federation, Slovakia, Czechia, Bulgaria, Moldova, Republic of, Poland
Celltrion

Recruiting

A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Healthy Subjects

Korea, Republic of
ISU Abxis Co., Ltd.

Completed

A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy Volunteers

Gaucher Disease

Australia
University Hospital Inselspital, Berne

Completed

The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1 | Exercise

Switzerland
Fresenius Kabi SwissBioSim GmbH

Completed

Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456

Healthy

New Zealand
University Hospital Tuebingen

Completed

Tocilizumab for the Treatment of Familial Mediterranean Fever

Familial Mediterranean Fever

Germany
Bio-Thera Solutions

Completed

Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects

Rheumatoid Arthritis

China
Northumbria University
Pronova BioPharma

Completed

The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood

Cognitive Function

United Kingdom
Pfizer

Completed

A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)

Metastatic Breast Cancer

Korea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
Asahi Kasei Pharma Corporation

Completed

Collagenase Option for Reduction of Dupuytren's Contracture in Japan (CORD-J)

Dupuytren's Contracture

Japan
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Severe Asthma

China
Bio-Thera Solutions

Active, not recruiting

A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects

Healthy Men

China
Guy's and St Thomas' NHS Foundation Trust
Oxford University Hospitals NHS Trust; NHS Greater Glasgow and Clyde; Northumbria... and other collaborators

Recruiting

Assess the Clinical Effectiveness in AI Prioritising CT Heads (ACCEPT)

Stroke, Ischemic | Skull Fractures | Trauma, Brain | Encephalomalacia | Mass Lesion | Hemorrhage, Intracranial | Midline Deviation

United Kingdom
Instituto de Investigación Marqués de Valdecilla

Withdrawn

Efficacy, Safety, and Immunogenicity of Vaccine Reimmunization With a Third Homologous Versus Heterologous Dose Against COVID-19 in Patients Undergoing Solid Organ Transplantation. (REIN-TX)

Covid19

Spain
The Christie NHS Foundation Trust
Novartis; East and North Hertfordshire NHS Trust; Mateon Therapeutics

Terminated

PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer (PAZOFOS)

Ovarian Neoplasms | Ovarian Cancer | Neoplasms, Ovarian

United Kingdom
Armando Santoro, MD

Terminated

Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients

NON-SMALL CELL LUNG CANCER

Italy
University of Cincinnati
Ohio Third Frontier; Wright Center of Innovation in Biomedical Imaging

Active, not recruiting

Assessing Environmental Factors in Healthcare Facilities in Order to Improve the Experience of Patients, Staff, and the Quality of Imaging Procedures

Healthcare Facility Environment - Imaging

United States
Baylor College of Medicine
National Institute of Nursing Research (NINR)

Completed

Aggression Prevention Training for Caregivers of Persons With Dementia (APT) (APT)

Aggression | Depression | Pain | Dementia | Alzheimer's Disease | Interpersonal Relations
University Medical Center Groningen
Dutch Kidney Foundation; Amphia Hospital; Healthy.io Ltd.; E-Zorg B.V. / KPN Health and other collaborators

Enrolling by invitation

Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches (THOMAS)

Albuminuria

Netherlands
Kythera Biopharmaceuticals

Completed

Open-Label Pharmacokinetic Study of Final Formulations of ATX-101

Healthy

United States
Samsung Bioepis Co., Ltd.

Terminated

A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC

Breast Neoplasms

Ukraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
Swiss Group for Clinical Cancer Research

Terminated

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Breast Cancer

Switzerland, Italy
mAbxience Research S.L.

Completed

A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced Xgeva

Healthy Volunteers

Poland
Samsung Bioepis Co., Ltd.

Completed

A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer

HER2 Positive Early or Locally Advanced Breast Cancer

Czechia
Bio-Thera Solutions

Completed

Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

China
AdventHealth

Withdrawn

Endoscopic Ultrasound (EUS) Processor Comparison

Pancreatitis | Pancreatic Carcinoma

United States
East and North Hertfordshire NHS Trust
University of Hertfordshire

Unknown

Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS (VaLiDate-R)

Acute Coronary Syndrome

United Kingdom
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Moderate to Severe Rheumatoid Arthritis (Auriel-RA)

Moderate to Severe Rheumatoid Arthritis

Bulgaria, United Kingdom, Hungary, Czechia, Poland, Germany
Sinocelltech Ltd.

Completed

Pharmacokinetics and Safety in Healthy Volunteers

Healthy

China
Bristol-Myers Squibb

Completed

Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer

Breast Cancer

Australia, Hungary, Canada, United Kingdom, Belgium
Fundación para la Investigación del Hospital Clínico...
Universitat Politècnica de València

Completed

Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring

Hypoglycemia | Type 1 Diabetes | Continuous Glucose Monitoring

Spain
Celltrion

Recruiting

To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis

Moderate to Severe Chronic Plaque Psoriasis

Estonia
H. Lundbeck A/S

Completed

Observational Study in Multiple System Atrophy (TALISMAN)

Multiple System Atrophy

China
Egas Moniz - Cooperativa de Ensino Superior, CRL

Completed

Study of the Neurophysiological Response to Foodstuffs

Healthy Nutrition

Portugal
Sandoz

Completed

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration (Mylight)

Neovascular Age-related Macular Degeneration

United States, Bulgaria, Czechia, Australia, Austria, France, Germany, Hungary, Israel, Japan, Latvia, Lithuania, Poland, Portugal, Slovakia, Spain
Bio-Thera Solutions

Active, not recruiting

Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients

Plaque Psoriasis

China
Samsung Bioepis Co., Ltd.

Completed

Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects

Healthy

Germany
Augusta University
University of Iowa; Teikyo University

Recruiting

Investigation of Alanine in Fructose Intolerance: A Dose Ranging Study

Fructose Intolerance

United States
University of North Carolina, Chapel Hill

Completed

Effect of Beta-Alanine on Heart Rate Response

Fatigue | Exercise

United States
Bio-Thera Solutions

Completed

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

Psoriasis

China
Celltrion

Completed

Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

Healthy Subjects

New Zealand

Search clinical trials for: Herceptin EU

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations